Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

EVG.L News

Evgen Pharma to advance SFX-01 trial with University of Dundee
5 Dec 2019

Evgen Pharma to advance SFX-01 trial with University of Dundee

(Sharecast News) - Clinical-stage drug development company Evgen Pharma has entered into a memorandum of understanding with the University of Dundee, ...

Evgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 Trials
5 Dec 2019

Evgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 Trials

Evgen Pharma, University Of Dundee To Collaborate To Advance SFX-01 Trials

UPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid Development
11 Nov 2019

UPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid Development

UPDATE: Evgen Pharma "Unlikely" To Pursue Subarachnoid Development

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance
11 Nov 2019

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance

UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance

Evgen Pharma Shares Drop On "Disappointing" SFX-01 Trial Results
11 Nov 2019

Evgen Pharma Shares Drop On "Disappointing" SFX-01 Trial Results

Evgen Pharma Shares Drop On "Disappointing" SFX-01 Trial Results

Evgen Pharma "Delighted" With Extended Breast Cancer Treatment Results
23 Sep 2019

Evgen Pharma "Delighted" With Extended Breast Cancer Treatment Results

Evgen Pharma "Delighted" With Extended Breast Cancer Treatment Results

Evgen Pharma upbeat on latest news from SFX-01 studies
23 Sep 2019

Evgen Pharma upbeat on latest news from SFX-01 studies

(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Monday that five patients who participated in the 'STEM' trial re...

Evgen Pharma completes patient study visits in 'SAS' phase 2 trial
28 Aug 2019

Evgen Pharma completes patient study visits in 'SAS' phase 2 trial

(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Wednesday that the last study visit for the last patient entered ...